← Back to the biomarker database

Estrogen breakdown: the pathway in the body

This page shows the biochemical pathway behind the laboratory value Estrogen metabolites, β-glucuronidase: which stations follow one another, which enzymes carry out each step and which cofactors they use. Every statement has a source. The page describes general textbook knowledge and says nothing about any individual person.

In brief

Estrogen metabolites are the conversion products of estradiol and estrone. Liver enzymes first attach OH groups, methylate them and add sugar or sulfate groups; in the gut, bacteria can undo that linkage again.

11 stations · 9 sources
ORYIn the liverIn the gutCYP3A4NADPH17β-HSD type 2NAD⁺CYP1A1, CYP1A2NADPHCYP1B1NADPHCOMTSAMmagnesiumCOMTSAMmagnesiumUGT, SULTUDP-glucuronic acidβ-glucuronidasevia the bile into the gutEstradiolmost potent estrogenEstronemilder intermediate form2-hydroxyestronephase I product4-hydroxyestronephase I product16α-hydroxyestronephase I product2-methoxyestronephase II product4-methoxyestronephase II productEstrogen glucuronidemade water-solubleGlucuronide in the gutarrived with the bileFree estrogensugar residue removedOut with the stoolend of the route

Swipe the graphic sideways

The pathway step by step

  1. Estradiol → Estrone 17β-HSD type 2 · NAD⁺ 17β-hydroxysteroid dehydrogenases interconvert estradiol and estrone: type 2 forms estrone, type 1 forms estradiol. Further breakdown usually starts from estrone. Source 2
  2. Estrone → 2-hydroxyestrone CYP1A1, CYP1A2 · NADPH In the liver, enzymes of the cytochrome P450 family attach an OH group to the ring. CYP1A1 and CYP1A2 prefer position 2. The result is a catechol, a ring with two OH groups. Source 3
  3. Estrone → 4-hydroxyestrone CYP1B1 · NADPH CYP1B1 places the OH group at position 4. This is also a catechol; it is more easily oxidised further to reactive intermediates, which methylation in the next step intercepts. Source 3, 4
  4. Estrone → 16α-hydroxyestrone CYP3A4 · NADPH CYP3A4 attaches the OH group at position 16, at the end of the second ring. Unlike the two catechols, this product still binds to the estrogen receptor. Source 4, 3
  5. 2-hydroxyestrone → 2-methoxyestrone COMT · SAM, magnesium Catechol-O-methyltransferase (COMT) transfers a methyl group from SAM to one of the two OH groups. This makes the molecule unreactive and easier to excrete; COMT needs magnesium. Source 4
  6. 4-hydroxyestrone → 4-methoxyestrone COMT · SAM, magnesium The same COMT also methylates the 4-form. Both routes thus end in a molecule that is not oxidised any further. Source 4
  7. 2-methoxyestrone → Estrogen glucuronide UGT, SULT · UDP-glucuronic acid UGT enzymes attach a sugar residue, sulfotransferases a sulphate group. Only then are the breakdown products water-soluble enough to leave via urine and bile. Source 5
  8. Glucuronide in the gut → Free estrogen β-glucuronidase Many gut bacteria produce the enzyme β-glucuronidase. It splits the sugar residue off again. The estrogen is then free and can pass back through the gut wall into the blood. Source 6, 7
  9. Glucuronide in the gut → Out with the stool Whatever stays bound and is not reabsorbed leaves the body with the stool. Source 7

Cofactors in this pathway

Sources

  1. Simpson ER, Mahendroo MS et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994 · PubMed 8076586
  2. Vihko P, Isomaa V et al. Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2. Mol Cell Endocrinol 2001 · PubMed 11165013
  3. Tsuchiya Y, Nakajima M et al. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005 · PubMed 16112414
  4. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998 · PubMed 9472688
  5. Raftogianis R, Creveling C et al. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000 · PubMed 10963623
  6. Ervin SM, Li H et al. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem 2019 · PubMed 31636122
  7. Baker JM, Al-Nakkash L et al. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas 2017 · PubMed 28778332
  8. Iyanagi T, Xia C, Kim JJ. NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family. Arch Biochem Biophys 2012 · PubMed 22982532
  9. Nissinen E, Männistö PT. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors. Int Rev Neurobiol 2010 · PubMed 21095460

Related pathways

As of 2026-09-16. Draft written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers